Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group
Journal of Clinical Oncology, 10/19/09
Hughes LL et al. – Rigorously evaluated and selected patients with low- to intermediate-grade DCIS with margins 3 mm or wider had an acceptably low rate of ipsilateral breast events at 5 years after excision without irradiation. Patients with high-grade lesions had a much higher rate, suggesting that excision alone is inadequate treatment.
Methods- Patients with either low- or intermediate-grade DCIS
- Measuring 2.5 cm or smaller, or high-grade DCIS measuring 1 cm or smaller with microscopic margin widths of 3 mm or wider
- No residual calcifications on postoperative mammograms eligible for prospective trial conducted from 1997 to 2002 by Eastern Cooperative Oncology Group and North Central Cancer Treatment Group
- Patients entered in 2000 and later could take tamoxifen if desired
- Median age at last surgery for entire population was 60 years (range, 28 to 88 years), and median tumor sizes in 2 strata were 6 mm and 5 mm, respectively
- With median follow-up of 6.2 years, 5-year rate of ipsilateral breast events in 565 eligible patients in low/intermediate grade stratum was 6.1%
- With median follow-up of 6.7 years, this incidence for 105 eligible patients in high-grade stratum was 15.3%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis
Cancer Letters, 11/20/09
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
Molecular Cancer, 11/20/09
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration
World Journal of Surgical Oncology, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


